Akthelia Pharmaceuticals - Reykjavík, Iceland

Akthelia is a rising pharmaceutical company devoted to finding and creating new anti-microbial remedies that strengthen the body's natural microbial defenses. The widespread resistance to antibiotic treatments that are already available has created a need for new anti-infective agents that can work against drug-resistant bacteria, opportunistic infections, and acute illnesses of unknown origins. Akthelia's product pipeline is varied and currently focuses on lung and gastrointestinal infections. With the help of researchers from the Karolinska Institute in Stockholm and the University of Iceland, Akthelia is gaining evidence of new active ingredients and methods of action. This research is helping to expand their product pipeline and generate new product prospects for future development.